ID

12471

Description

The purpose of the study is to assess the efficacy (prevention of vascular events) and safety (especially bleedings) of Ticagrelor (AZD6140) compared with Clopidogrel, both given on top of low dose aspirin, in Asian/Japanese patients with acute coronary syndrome and a planned percutaneous coronary intervention (PCI). https://clinicaltrials.gov/ct2/show/NCT01294462

Lien

https://clinicaltrials.gov/ct2/show/NCT01294462

Mots-clés

Versions (2)
  1. 28/07/2015 28/07/2015 -
  2. 21/11/2015 21/11/2015 -
Téléchargé le

21 novembre 2015

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Ticagrelor Versus Clopidogrel Acute Coronary Syndrome NCT01294462

Anglais

Eligibility criteria

1 Formulaires  
  1. StudyEvent: ODM
    1. Eligibility criteria
Inclusion Criteria
Description

Inclusion Criteria

Provision of signed informed consent
Description

Provision of signed informed consent

Type de données

boolean

Alias
UMLS CUI-1
C0021430
Index event of ST segment elevation ACS
Description

Index event of non-ST or ST segment elevation ACS

Type de données

boolean

Alias
UMLS CUI-1
C1536220
Index event of non-ST segment elevation ACS
Description

Index event of non-ST segment elevation ACS

Type de données

boolean

Alias
UMLS CUI-1
C3537184
Exclusion criteria
Description

Exclusion criteria

Index event is an acute complication of percutaneous coronary intervention
Description

Index event is an acute complication of percutaneous coronary intervention

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009566
UMLS CUI [1,2]
C1532338
Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
Description

Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment

Type de données

boolean

Alias
UMLS CUI-1
C1532338
Oral anticoagulation therapy that cannot be stopped
Description

Oral anticoagulation therapy that cannot be stopped

Type de données

boolean

Alias
UMLS CUI-1
C0003281
The conditions associated with increased risk of bradycardiac events
Description

The conditions associated with increased risk of bradycardiac events

Type de données

boolean

Alias
UMLS CUI-1
C0428977
Retour au début de la page

Similar models

Eligibility criteria

1 Formulaires
  1. StudyEvent: ODM
    1. Eligibility criteria
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Inclusion Criteria
Informed consent
Item
Provision of signed informed consent
boolean
C0021430 (UMLS CUI-1)
STEMI
Item
Index event of ST segment elevation ACS
boolean
C1536220 (UMLS CUI-1)
NSTEMI
Item
Index event of non-ST segment elevation ACS
boolean
C3537184 (UMLS CUI-1)
Item Group
Exclusion criteria
PCI complication
Item
Index event is an acute complication of percutaneous coronary intervention
boolean
C0009566 (UMLS CUI [1,1])
C1532338 (UMLS CUI [1,2])
PCI
Item
Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
boolean
C1532338 (UMLS CUI-1)
anticoagulation therapy
Item
Oral anticoagulation therapy that cannot be stopped
boolean
C0003281 (UMLS CUI-1)
Bradycardia
Item
The conditions associated with increased risk of bradycardiac events
boolean
C0428977 (UMLS CUI-1)
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial